Task: Answer the multiple-choice question.
Query: Which compound exhibits a 4.186\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a N#CC(C#N)=Cc1ccc(-c2ccccc2F)o1
b Cn1c(=NC(=O)COc2ccccc2)sc2cccc(F)c21
c Clc1cccc(CN2CCc3c([nH]c4ccccc34)C2)c1Cl
Answer: b. Cn1c(=NC(=O)COc2ccccc2)sc2cccc(F)c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(=NC(=O)COc2ccccc2)sc2cccc(F)c21
Cn1c(=NC(=O)COc2ccccc2)sc2cccc(F)c21
N-(4-fluoro-3-methyl-1,3-benzothiazol-2-ylidene)-2-phenoxyacetamide